A paclitaxel-coated balloon, Agent DCB (Boston Scientific), was superior to an uncoated balloon for treating coronary in-stent restenosis in patients undergoing percutaneous coronary intervention (PCI ...

Compared with standard balloon angioplasty, the drug-coated balloon strategy appeared to suppress recurrent ISR over six months in a 52-patient study, published online November 13, 2006 in the New ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These ...

Please provide your email address to receive an email when new articles are posted on . Balloon angioplasty and stent implantation procedures in the early postoperative period after congenital heart ...

Please provide your email address to receive an email when new articles are posted on . A drug-coated balloon produced better clinical outcomes than angioplasty at 1 year in patients with coronary ...

Drug-coated balloons are gaining attention as a stent-free angioplasty option, offering a “leave nothing behind” approach ...

Stent grafts may be more effective than balloon angioplasty in prolonging the function of stenosed arteriovenous access grafts and in lowering the likelihood of requiring additional interventions, ...

CHICAGO, Ill. (March 31, 2008) — An angioplasty balloon coated with a drug that reduces renarrowing of the coronary arteries appears to be more effective than a drug-eluting stent in treating an ...

MINNEAPOLIS –– Advancing the treatment of peripheral artery disease, Medtronic, Inc. today announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant® Cobalt Iliac ...